SCHEMBL7707870

SCHEMBL7707870

CC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]([C]=O)CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 3/20 0.49
GNPAT O15228 1/20 0.48
SIRT5 Q9NXA8 2/20 0.40
CPA1 P15085 1/20 0.38
CPA2 P48052 1/20 0.38
CPA4 Q9UI42 1/20 0.38
FOLH1 Q04609 5/20 0.38
NAALAD2 Q9Y3Q0 3/20 0.38
RIMKLA Q8IXN7 1/20 0.38
PTPN1 P18031 1/20 0.36
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34
NFKB1 P19838 1/20 0.34
PTGS2 P35354 1/20 0.34
THPO P40225 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2190405 0.84 GNPAT (0.47) GNPATSIRT5MMP1
SCHEMBL7886832 0.84 DPP4 (0.46) BMP1GNPATFOLH1NAALAD2RIMKLA
SCHEMBL9700817 0.83 GNPAT (0.41) BMP1GNPATCPA1CPA2CPA4
SCHEMBL1352873 0.83 BMP1 (0.46) BMP1GNPATSIRT5PTPN1
Isospaglumic Acid SCHEMBL288514 0.80 GNPAT (0.70) BMP1GNPATFOLH1NAALAD2RIMKLA
Isospaglumic Acid SCHEMBL27542882 0.80 GNPAT (0.70) BMP1GNPATFOLH1NAALAD2RIMKLA
SCHEMBL31194414 0.80 GNPAT (0.70) BMP1GNPATFOLH1NAALAD2RIMKLA
Isospaglumic Acid SCHEMBL288515 0.80 GNPAT (0.70) BMP1GNPATFOLH1NAALAD2RIMKLA
Isospaglumic Acid SCHEMBL31121839 0.80 GNPAT (0.70) BMP1GNPATFOLH1NAALAD2RIMKLA
SCHEMBL2248714 0.79 GNPAT (0.60) BMP1GNPATSIRT5CPA1CPA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6335320-B1 Method of treating fibrotic conditions UCB S.A. (BE) 2002-01-01 US claimed
EP-1140202-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2001-10-10 EP claimed
WO-2000038733-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2000-07-06 WO claimed
US-6335320-B1 Method of treating fibrotic conditions UCB S.A. (BE) 2002-01-01 US disclosed
US-6335320-B1 Method of treating fibrotic conditions UCB S.A. (BE) 2002-01-01 US disclosed
EP-1140202-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2001-10-10 EP disclosed
EP-1140202-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2001-10-10 EP disclosed
WO-2000038733-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2000-07-06 WO disclosed
WO-2000038733-A1 PEPTIDIC PRODUCT, PROCESS AND COMPOSITION UCB S.A. (BE) 2000-07-06 WO disclosed